116 related articles for article (PubMed ID: 17460891)
21. The therapeutic potential of SA-sCD40L in the orthotopic model of superficial bladder cancer.
Zhang Z; Xu X; Zhang X; Chen X; Chen Q; Dong L; Hu Z; Li J; Gao J
Acta Oncol; 2011 Oct; 50(7):1111-8. PubMed ID: 21247263
[TBL] [Abstract][Full Text] [Related]
22. Comparison of three different targeted tissue factor fusion proteins for inducing tumor vessel thrombosis.
Hu P; Yan J; Sharifi J; Bai T; Khawli LA; Epstein AL
Cancer Res; 2003 Aug; 63(16):5046-53. PubMed ID: 12941833
[TBL] [Abstract][Full Text] [Related]
23. Fusion protein tTF-EG3287 induces occlusion of tumor vessels and impairs tumor growth in human colon caner.
Qiu GQ; Xie X; Zhao B; Xu LZ; Chen YQ
Neoplasma; 2019 Mar; 66(2):252-260. PubMed ID: 30569722
[TBL] [Abstract][Full Text] [Related]
24. Construction and characterization of a truncated tissue factor‑coagulation‑based composite system for selective thrombosis in tumor blood vessels.
Xu P; Zou M; Wang S; Li T; Liu C; Wang L; Wang L; Luo F; Wu T; Yan J
Int J Oncol; 2019 Oct; 55(4):823-832. PubMed ID: 31432158
[TBL] [Abstract][Full Text] [Related]
25. The pilot-scale preparation of the SA-hGM-CSF bi-functional fusion protein.
Li X; Zhou S; Wang Y; Lian H; Zuo A; Zhou K; Tong L; Zhou Z; Gao J
Bioengineered; 2019 Dec; 10(1):108-120. PubMed ID: 31017543
[TBL] [Abstract][Full Text] [Related]
26. Cloning of alpha-beta fusion gene from Clostridium perfringens and its expression.
Bai JN; Zhang Y; Zhao BH
World J Gastroenterol; 2006 Feb; 12(8):1229-34. PubMed ID: 16534876
[TBL] [Abstract][Full Text] [Related]
27. [Expression of fusion protein encoding EGFP-EGF1 of rat coagulation factor VII and its binding function].
May H; Hu Y; Zhang YH; Wang HF; Fang J; Guo T; Wei WN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):181-4. PubMed ID: 18315926
[TBL] [Abstract][Full Text] [Related]
28. [Preparation and bioactivity evaluation of streptavidin-tagged human interferon- inducible T cell alpha chemoattractant bifunctional fusion protein].
Xu X; Liu Y; Chen Q; Huang T; Gao J
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1715-20. PubMed ID: 26714903
[TBL] [Abstract][Full Text] [Related]
29. [Construction of prokaryotic expression plasmid pET15b-PEP-1-CAT and expression and purification of PEP-1-CAT fusion protein].
Yao LL; Wang JN; Huang YZ; Guo LY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1319-25. PubMed ID: 16982446
[TBL] [Abstract][Full Text] [Related]
30. In vivo biotinylated recombinant antibodies: construction, characterization, and application of a bifunctional Fab-BCCP fusion protein produced in Escherichia coli.
Weiss E; Chatellier J; Orfanoudakis G
Protein Expr Purif; 1994 Oct; 5(5):509-17. PubMed ID: 7827508
[TBL] [Abstract][Full Text] [Related]
31. Preclinical evaluation of a humanized NR-LU-10 antibody-streptavidin fusion protein for pretargeted cancer therapy.
Goshorn S; Sanderson J; Axworthy D; Lin Y; Hylarides M; Schultz J
Cancer Biother Radiopharm; 2001 Apr; 16(2):109-23. PubMed ID: 11385958
[TBL] [Abstract][Full Text] [Related]
32. [Prokaryotic expression and function detection of Mycobacterium tuberculosis Hsp16.3].
Qin H; Gao S; Yuan J; Xu L; Luo J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):480-4. PubMed ID: 24796742
[TBL] [Abstract][Full Text] [Related]
33. [Preparation and bioactivity evaluation of SA-mIL15 fusing protein].
Chen YL; Xu XL; Tang J; Nie XX; Song ZC; Hu ZM; Gao JM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Feb; 26(2):107-10. PubMed ID: 20230665
[TBL] [Abstract][Full Text] [Related]
34. Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization.
Stone MJ; Ruf W; Miles DJ; Edgington TS; Wright PE
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):605-14. PubMed ID: 7654202
[TBL] [Abstract][Full Text] [Related]
35. Novel superparamagnetic iron oxide nanoparticles for tumor embolization application: preparation, characterization and double targeting.
Chen X; Lv H; Ye M; Wang S; Ni E; Zeng F; Cao C; Luo F; Yan J
Int J Pharm; 2012 Apr; 426(1-2):248-255. PubMed ID: 22310463
[TBL] [Abstract][Full Text] [Related]
36. Expression and purification of exendin-4 dimer in Escherichia coli and its interaction with GLP-1 receptor in vitro.
Yi L; Yin X; Wei D; Ma Y
Protein Pept Lett; 2006; 13(8):823-7. PubMed ID: 17073729
[TBL] [Abstract][Full Text] [Related]
37. [Fusion expression and identification of angiostatin and endostatin in E. coli BL21(DE3)].
Mao X; Liu W; Fu S; Li R; Liang G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Oct; 23(5):1086-91. PubMed ID: 17121360
[TBL] [Abstract][Full Text] [Related]
38. Expression of Mastoparan B, a Venom Peptide, Via Escherichia coli C43 (DE3) Coupled with an Artificial Oil Body-Cyanogen Bromide Technology Platform.
Hsieh SK; Yu YJ; Tang NY; Lin JR; Jinn TR
Protein Pept Lett; 2017; 24(11):1021-1029. PubMed ID: 28741464
[TBL] [Abstract][Full Text] [Related]
39. Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion.
Kipriyanov SM; Little M; Kropshofer H; Breitling F; Gotter S; Dübel S
Protein Eng; 1996 Feb; 9(2):203-11. PubMed ID: 9005442
[TBL] [Abstract][Full Text] [Related]
40. Biotin carboxyl carrier protein co-purifies as a contaminant in core-streptavidin preparations.
Wang WW; Das D; Suresh MR
Mol Biotechnol; 2005 Sep; 31(1):29-40. PubMed ID: 16118413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
